Nucleocapsid (N) gene mutations of sars-cov-2 can affect real-time rt-pcr diagnostic and impact false-negative results
Nenhuma Miniatura disponível
Data
2021-12-01
Autores
Lesbon, Jéssika Cristina Chagas
Poleti, Mirele Daiana
de Mattos Oliveira, Elisângela Chicaroni
Patané, José Salvatore Leister
Clemente, Luan Gaspar
Viala, Vincent Louis
Ribeiro, Gabriela
Giovanetti, Marta
de Alcantara, Luiz Carlos Junior
de Lima, Loyze Paola Oliveira
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
The current COVID-19 pandemic demands massive testing by Real-time RT-PCR (Reverse Transcription Polymerase Chain Reaction), which is considered the gold standard diagnostic test for the detection of the SARS-CoV-2 virus. However, the virus continues to evolve with mutations that lead to phenotypic alterations as higher transmissibility, pathogenicity or vaccine evasion. Another big issue are mutations in the annealing sites of primers and probes of RT-PCR diagnostic kits leading to false-negative results. Therefore, here we identify mutations in the N (Nucleocapsid) gene that affects the use of the GeneFinder COVID-19 Plus RealAmp Kit. We sequenced SARS-CoV-2 genomes from 17 positive samples with no N gene detection but with RDRP (RNA-dependent RNA polymerase) and E (Envelope) genes detection, and observed a set of three different mutations affecting the N detection: a deletion of 18 nucleotides (Del28877-28894), a substitution of GGG to AAC (28881-28883) and a frameshift mutation caused by deletion (Del28877-28878). The last one cause a deletion of six AAs (amino acids) located in the central intrinsic disorder region at protein level. We also found this mutation in 99 of the 14,346 sequenced samples by the Sao Paulo state Network for Pandemic Alert of Emerging SARS-CoV-2 variants, demonstrating the circulation of the mutation in Sao Paulo, Brazil. Continuous monitoring and characterization of mutations affecting the annealing sites of primers and probes by genomic surveillance programs are necessary to maintain the effectiveness of the diagnosis of COVID-19.
Descrição
Palavras-chave
COVID-19, GeneFinder, Mutation, N gene, RT-PCR
Como citar
Viruses, v. 13, n. 12, 2021.